Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Overexpression and Translocation of Dynamin 2 Promotes Tumor Aggressiveness in Breast Carcinomas Publisher



Sajed R1, 2 ; Zanjani LS2 ; Rahimi M3 ; Mansoori M1, 2 ; Zarnani AH4, 5 ; Madjd Z1, 2 ; Ghods R1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medicine Sciences (IUMS), Tehran, Iran
  2. 2. Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
  3. 3. Hasheminejad Kidney Center, Pathology Department, Iran University of Medical Sciences (IUMS), Tehran, Iran
  4. 4. Department of Immunology, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  5. 5. Reproductive Immunology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran

Source: EXCLI Journal Published:2020


Abstract

Dynamin 2 is a GTPase protein that has been implicated in cancer progression through its various roles such as endocytosis, morphogenesis, epithelial-mesenchymal transition (EMT), cellular contractions, and focal adhesion maturation. The increased expression levels of this molecule have been demonstrated with the development of several cancers such as prostate, pancreas, and bladder. However, its clinical significance in breast cancer is un-clear yet. In the present study, the membranous, cytoplasmic, and nuclear expression levels of dynamin 2 molecule were evaluated for the first time, using immunohistochemistry (IHC) on tissue microarray (TMA) slides in 113 invasive breast cancer tissues. Moreover, afterward, the association between the dynamin 2 expression and clini-copathological features was determined. Our finding showed that, a higher nuclear expression of dynamin 2 is significantly associated with an increase in tumor stage (P = 0.05), histological grade (P = 0.001), and age of the patients (P = 0.03). In addition, analysis of the cytoplasmic expression levels of this molecule revealed that, there was a statistically significant difference between the expression levels of dynamin 2 among the different breast cancer subtypes (P = 0.003). Moreover, a significant association was found between the increased expression of dynamin 2 membranous and vascular invasion (VI) (P = 0.02). We showed that dynamin 2 protein expression has an association with more aggressive tumor behavior and more advanced disease in the patients with breast cancer; therefore, dynamin 2 molecule could be considered as an indicator of disease progression and aggressiveness. © 2020, Leibniz Research Centre for Working Environment and Human Factors. All rights reserved.